SciClone, National Institutes of Health deal

SCLN licensed CPX (8-cyclopentyl-1, 3-dipropylxanthine), a potential treatment for cystic fibrosis, from the NIH. CPX is a gene-assist therapy that is believed to bind to the cystic fibrosis transmem...